Fairvalue-Calculator Fairvalue-Calculator
EN DE

Balaxi Pharmaceuticals Limited (BALAXI) Fair Value & Analysis

Healthcare · IN · Market cap ₹1.3B

Price₹23.12
Fair Value₹11.05
Upside-52.2%
Quality97/100
Evidence: Medium Range ₹7.74 – ₹14.37

Fair value as of: Jun 29, 2026

✦ Which stocks are undervalued right now? Check free Discover now →

Analysis

Balaxi Pharmaceuticals Limited (BALAXI) currently trades at ₹23.12, while our model-based Fair Value estimate is ₹11.05 — implying the stock looks roughly 52.2% overvalued today. We read business quality at 97/100 (high quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: medium).

About the company

Balaxi Pharmaceuticals Limited engages in the international wholesale distribution of pharmaceuticals, builders hardware, and FMCG products in India, Africa, and Latin America. The company offers pharmaceutical products across various therapeutic areas, including antibiotics, analgesic, anti-malaria, and others. It also provides biscuits and toothpaste. The company was formerly known as Balaxi Ventures Limited and changed its name to Balaxi Pharmaceuticals Limited in October 2020. The company was incorporated in 1942 and is headquartered in Hyderabad, India. Balaxi Pharmaceuticals Limited is a subsidiary of Balaxi Overseas Private Limited.

Open the full interactive analysis →

Similar stocks

Jiangsu Hengrui Pharmaceuticals Co (600276) -43% Sun Pharmaceutical Industries Limited (SUNPHARMA) -49% Zoetis Inc (Z1TS34) -24% Hansoh Pharmaceutical Group (3692) -18% Divi's Laboratories Limited (DIVISLAB) -81% Swedish Orphan Biovitrum AB (SOBI) -1%

Frequently asked questions

Is Balaxi Pharmaceuticals Limited (BALAXI) undervalued?
As of Jun 29, 2026, our model estimates a fair value of ₹11.05 versus a price of ₹23.12 — about −52% (overvalued). Model-based estimate, not financial advice.
What is the fair value of BALAXI?
Our 21-model fair value for Balaxi Pharmaceuticals Limited is ₹11.05 (as of Jun 29, 2026), built from audited fundamentals. The current price is ₹23.12.
What is the quality score of BALAXI?
Balaxi Pharmaceuticals Limited has a Quality Score of 97/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.